Tag: Biotechnologies

Biotechnology is the use of living systems and organisms to develop or make products, or “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use”. Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, biomanufacturing, molecular engineering, etc.

Bayer and Ginkgo Bioworks will create new biotech company

Bayer
Bayer and Ginkgo Bioworks will create a new company focused on the plant microbiome

BMS and Halozyme will develop new drug-delivery technology

bms
Bristol-Myers Squibb and Halozyme Therapeutics today announced a global collaboration and license agreement

India and Japan signed a Memorandum for a collaboration in biotech area

india-japan
India and Japan today signed a MoU for expansion of an international laboratory set up for a collaborative research in the area of biotechnology.

Kaneka Eurogentec will construct new GMP facility

pharma-manufacturing
Kaneka Eurogentec announced that its board has approved the construction of a new state of-the-art GMP facility

LakePharma launched new biotech facility in California

biotechnologies
LakePharma announced it has expanded its Antibody Center into a new facility located in South San Francisco

Chile interested in expanding cooperation with St. Petersburg Research Institute

chile
A meeting between the representatives of Instituto de Salud Pública, Chile, and St. Petersburg Research Institute of Vaccines and Serums was held in St. Petersburg.

Ingenza purchased new high performance bioreactor system

biotech
Leading industrial biotechnology company Ingenza has acquired a high performance benchtop bioreactor system to enable faster development of new fermentation processes. The Sartorius ambr® 250 modu...

Bioverativ and Bicycle Therapeutics will jointly work on blood disease therapies

blood
Bioverativ Inc and Bicycle Therapeutics Ltdtoday announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell disease

BIOCAD opens the Faculty of Molecular and Cell Biotechnology

research
On September 4, 2017, the students of the new Faculty began to attend their classes. This was preceded by a rigorous competitive selection, which revealed the best of the best.

Belarus made progress in the area of biopharmaceuticals and biomedicine

biotech
Over the five years, Belarus produced biotech products worth more than $3 billion, said Emilia Kolomiets, the Director of the Institute of Microbiology of the National Academy of Sciences of Belarus

Atreca biotechnology company received $35 million investment

biotechnology
Atreca, Inc. yesterday announced the completion of its Series B round of financing with a total investment of $35 million

Horizon Discovery buys gene-editing business from General Electric

gene
Horizon Discovery Group, a global leader in the application of gene editing technologies, today announces that it has entered into an agreement to acquire Dharmacon from General Electric Company

Canopy Biosciences launched host cell protein detection kits

gene editing
Canopy Biosciences announced that it will enter the bioprocessing field by marketing kits for host cell protein detection

Horizon Discovery gained exclusive license for its gene editing technology

gene-editing
Horizon Discovery Group announced the completion of licensing agreements with all joint patent holders to provide exclusive worldwide rights to a novel transposon-based gene editing technology platform

Locus Biosciences obtained $5 million investment

biotechnologies
Locus Biosciences Inc. announced the closing of a $5M Convertible Note to support the development of CRISPR-Cas3 antimicrobial therapeutics

Researchers at Siberian State Medical University use “green chemistry”

science
The researchers of the Siberian State Medical University in Tomsk are developing a biotech method for obtaining antimicrobial peptides to synthesize a drug for radionuclide diagnostics of infectious inflammations